AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Recruiting · NCT05351424 · Interventional (participants receive a specific treatment) · Lead sponsor: Columbia University
View the official record on ClinicalTrials.gov →Interventions studied
ASTRO Radiation Therapy for Breast or Prostate Cancer BrochureAudiovisual Intervention- Cancer Clinical Trials EducationAudiovisual Intervention- Radiation Therapy EducationNCI Taking Part in Cancer Research Studies Brochure
What this trial is about
The study aims to develop educational media interventions to prepare Latinx Spanish-speaking radiation oncology patients for a course of breast or prostate cancer radiation therapy and to foster receptivity and informed decision-making around cancer clinical trial participation.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry
- Currently undergoing treatment for breast or prostate cancer, or recently been treated
- Pilot Phase
Exclusion criteria
- Patient with bilateral deafness and/or blindness
- Patient with psychosis and/or dementia
- Main Study Inclusion Criteria:
- Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry
- Patients with non-metastatic prostate or breast cancer
- Histopathologically proven diagnosis of prostate or breast cancer
- History and physical examination within 28 days prior to enrollment
- Karnofsky performance status 70 or greater
- For women of childbearing potential, pregnancy testing to be performed in accordance to institutional guidelines
- Plan to receive definitive, curative radiation. Patients planning to receive curative RT after upcoming adjuvant chemotherapy or induction hormonal therapy may enroll at reconsult "follow-up" visit.
- Consultation visit must be performed with a certified interpreter
- Main Study Exclusion Criteria:
- Patient with bilateral deafness and/or blindness
- Patient with psychosis and/or dementia
- Clinical or radiological evidence of metastatic disease
- Prior participation in cancer patient education trial
- Prior RT
- RT for sites other than breast or prostate
Where it is running
2 locations listed across 2 US states.
- Mount Sinai Medical Center - Miami Beach, Florida, United States
- Columbia University Irving Medical Center - New York, New York, United States